BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5468048)

  • 1. Studies on an acid ribonuclease from corticoid-sensitive 9alpha-fluoroprednisolone-treated lymphosarcoma P1798: changes in heat inactivation kinetics of the enzyme due to steroid treatment.
    Biswas S; Hollander VP
    Cancer Res; 1970 Mar; 30(3):827-9. PubMed ID: 5468048
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell membrane sialoglycopeptides of corticoid-sensitive and -resistant lymphosarcoma P1798.
    Behrens UJ; Hollander VP
    Cancer Res; 1976 Jan; 36(1):172-80. PubMed ID: 946164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of in vitro glucocorticoid treatment on acid ribonuclease activity in P1798 lymphosarcoma cells.
    Mashburn LT; Freeman CY; Hollander VP
    Proc Soc Exp Biol Med; 1969 May; 131(1):108-11. PubMed ID: 5818823
    [No Abstract]   [Full Text] [Related]  

  • 4. Early effects of glucocorticoid treatment on amino acid metabolism in lymphosarcoma P1798.
    Stevens J; Stevens YW; Hollander VP
    Cancer Res; 1973 Feb; 33(2):370-4. PubMed ID: 4739450
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of starvation of intact and adrenalectomized mice bearing lymphosarcoma P1798 on tumor regression and ribonuclease activity.
    Wiernik PH
    Cancer Res; 1970 Feb; 30(2):280-2. PubMed ID: 5469006
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in ribonuclease activities in P1798 lymphosarcoma after asparaginase treatment.
    Mashburn LT; Landin LM
    Arch Biochem Biophys; 1968 Jun; 125(3):721-6. PubMed ID: 4876422
    [No Abstract]   [Full Text] [Related]  

  • 7. EFFECT OF CORTICOSTEROIDS ON RIBONUCLEASE AND NUCLEIC ACID CONTENT IN LYMPHOSARCOMA P1798.
    MACLEOD RM; KING CE; HOLLANDER VP
    Cancer Res; 1963 Aug; 23():1045-50. PubMed ID: 14050757
    [No Abstract]   [Full Text] [Related]  

  • 8. The purification and characterization of liver glyoxalase I from normal mice and from mice bearing a lymphosarcoma.
    Strzinek RA; Scholes VE; Norton SJ
    Cancer Res; 1972 Nov; 32(11):2359-64. PubMed ID: 4678085
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of ribonuclease in regression of lymphosarcoma P1798.
    Ambellan E; Hollander VP
    Cancer Res; 1966 May; 26(5):903-9. PubMed ID: 5952412
    [No Abstract]   [Full Text] [Related]  

  • 10. Further studies on liver glyoxalase activity in mice bearing lymphosarcoma.
    Strzinek RA; Vela GR; Scholes VE; Norton SJ
    Cancer Res; 1970 Feb; 30(2):334-7. PubMed ID: 5467457
    [No Abstract]   [Full Text] [Related]  

  • 11. Ribonuclease inhibitor in lymphosarcoma P1798: effects of steroid and 5-FU.
    Ambellian E; Hollander VP
    Proc Soc Exp Biol Med; 1968 Feb; 127(2):482-4. PubMed ID: 5694418
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of acetylcholine on the Na, K-ATPase activity of homogenates of rat spleen and lymphosarcoma].
    Mustafin AM; Seĭtkazina GD
    Biull Eksp Biol Med; 1981 Jun; 91(6):714-5. PubMed ID: 6268226
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective effect of cortisol on deoxyribonuclease II activity of lymphosarcoma P1798.
    Raina PN; Rosen F
    Arch Int Pharmacodyn Ther; 1969 Nov; 182(1):14-23. PubMed ID: 5395574
    [No Abstract]   [Full Text] [Related]  

  • 14. Tempol reduces the therapeutic effect of cyclophosphamide on an experimental tumour model.
    Kaledin VI; Popova NA; Nikolin VP; Vasilieva ED; Kirilyuk IA; Grigor'ev IA
    Free Radic Res; 2009 Jul; 43(7):685-90. PubMed ID: 19526393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid receptors and mechanism of resistance in the cortisol-sensitive and -resistant lines of lymphosarcoma P1798.
    Kaiser N; Milholland RJ; Rosen F
    Cancer Res; 1974 Mar; 34(3):621-6. PubMed ID: 4359883
    [No Abstract]   [Full Text] [Related]  

  • 16. [Influence of ribonuclease on experimental tumor growth].
    Manoĭlov SE; Orlova EI; Polosova RG
    Vopr Onkol; 1966; 12(1):64-9. PubMed ID: 6013690
    [No Abstract]   [Full Text] [Related]  

  • 17. Nonmutational alteration in glucocorticoid sensitivity of lymphosarcoma P1798.
    Davis JM; Chan AK; Thompson EA
    J Natl Cancer Inst; 1980 Jan; 64(1):55-62. PubMed ID: 6928047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined use of rubomycin and olivomycin in treatment of murine lymphosarcoma].
    Shopin VA; Kriatova GN
    Antibiotiki; 1972 Apr; 17(4):325-9. PubMed ID: 5068419
    [No Abstract]   [Full Text] [Related]  

  • 19. [Growth kinetics of transplanted lymphosarcoma NKLy in the ascitic and solid forms].
    Pelevina II; Afanas'ev GG; Lipchina LP; Andreev VM; Emanuel' NM
    Izv Akad Nauk SSSR Biol; 1966; 6():841-51. PubMed ID: 6015163
    [No Abstract]   [Full Text] [Related]  

  • 20. [Seasonal changes in the rate of development and sensitivity of lymphosarcoma to olivomycin in male and female albino mice].
    Averbukh LA; Shorin VA
    Antibiotiki; 1971 Mar; 16(3):224-8. PubMed ID: 5109158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.